Technology Behind
LipiDRONE-TriX® is a next-generation nanostructured lipid-based delivery system designed through advanced molecular engineering to revolutionize the transport and efficacy of bioactive compounds. Built upon Nanostructured Lipid Carrier (NLC) technology, it overcomes key limitations of conventional delivery systems by enhancing the stability, solubility, and targeted delivery of lipid-soluble actives. This technology integrates a dual-phase lipid matrix optimized at the nanoscale, which improves bioavailability, protects active compounds from degradation, and enables precise controlled release. The unique engineering of LipiDRONE-TriX® ensures that encapsulated bioactives maintain higher potency, extended circulation time, and deeper tissue penetration, unlocking their full potential for therapeutic and nutraceutical applications
Mechanism of Action
Lipid-soluble bioactives are encapsulated in nanoscale dual-phase lipid carriers, which protect them from degradation and enhance solubility. The nanostructure improves cellular uptake, enables controlled and sustained release, and ensures targeted delivery to tissues, increasing bioavailability, therapeutic efficacy, and patient compliance.
Higher Bioavailability & Efficacy
Overcomes poor solubility and absorption issues, ensuring maximum therapeutic effect.
Enhanced Stability & Protection –
Shields sensitive actives from environmental degradation, maintaining potency
Targeted Action & Better Performance
Facilitates deeper penetration into target tissues, increasing localized bioactivity.
Pharmacokinetics
Lipid-soluble bioactives are encapsulated in nanoscale dual-phase lipid carriers, which protect them from degradation and enhance solubility. The nanostructure improves cellular uptake, enables controlled and sustained release, and ensures targeted delivery to tissues, increasing bioavailability, therapeutic efficacy, and patient compliance.
No chart data available for this technology.